Simrat Randhawa, EVP, Head of R&D at Dianthus Therapeutics, Inc. /DE/ (DNTH), sold 33,830 shares at $81.48 ($2.8M) on 2026-03-12, disclosed to the SEC on 2026-03-13.
Open-market sale of $2.8M DNTH by EVP, Head of R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| DNTH | SELL | 2025-11-14 | $14.8M | — | Filing → |
| DNTH | BUY | 2023-09-25 | $53K | — | Filing → |